Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Covid-19"" wg kryterium: Temat


Tytuł:
How do people with long COVID utilize COVID-19 vaccination and rehabilitation services and what are their experiences with these services? results of a qualitative study with 48 participants from Germany.
Autorzy:
Schmachtenberg T; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany. .; Department of Rheumatology and Immunology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. .
Königs G; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany.
Roder S; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany.; Department of Social Work, University of Applied Sciences and Arts Bielefeld, Interaktion 1, 33619, Bielefeld, Germany.
Müller F; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany.; Department of Family Medicine, College of Human Medicine, Michigan State University, 15 Michigan St NE, Grand Rapids, 49503, East Lansing, MI, USA.
Müllenmeister C; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany.
Schröder D; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany.
El-Sayed I; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Mar 28; Vol. 24 (1), pp. 915. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
Vaccines*
Adult ; Humans ; Post-Acute COVID-19 Syndrome ; COVID-19 Vaccines ; Vaccination
Czasopismo naukowe
Tytuł:
Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease.
Autorzy:
Colaneri M; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.; Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.
Scaglione G; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Fassio F; Department of Public Health, Experimental and Forensic Medicine, Unit of Biostatistics and Clinical Epidemiology, University of Pavia, Pavia, Italy.
Galli L; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Lai A; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
Bergna A; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
Gabrieli A; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
Tarkowski M; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
Ventura CD; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
Colombo V; Department of Infectious Diseases, Unit I, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Cordier L; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Bernasconi D; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Corbellino M; Institute of Infectious Diseases & Tropical Medicine, III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Dedivitiis G; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Borghetti S; Pharmacy Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Visigalli D; Pharmacy Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Sollima S; Institute of Infectious Diseases & Tropical Medicine, III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Casalini G; Institute of Infectious Diseases & Tropical Medicine, III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Rizzardini G; Department of Infectious Diseases, Unit I, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Gori A; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.; Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.
Antinori S; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.; Institute of Infectious Diseases & Tropical Medicine, III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Riva A; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.; Institute of Infectious Diseases & Tropical Medicine, III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Schiavini M; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2024 Mar 20; Vol. 21 (1), pp. 68. Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
SARS-CoV-2*
COVID-19*
Lactams*
Leucine*
Nitriles*
Proline*
Humans ; Antibodies, Monoclonal/therapeutic use ; Ritonavir/therapeutic use ; COVID-19 Vaccines ; Retrospective Studies ; COVID-19 Drug Treatment ; Antiviral Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review.
Autorzy:
Duan C; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu, 610041, China.
Liu L; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu, 610041, China.; Department of Conservative Dentistry and Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Wang T; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu, 610041, China.
Wang G; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu, 610041, China.; Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Jiang Z; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu, 610041, China.
Li H; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu, 610041, China.; Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Zhang G; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu, 610041, China.; Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Ye L; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu, 610041, China.; Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Li C; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu, 610041, China.; Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.; Department of Evidence-Based Stomatology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Cao Y; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu, 610041, China. .; Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu, China. .; Department of Evidence-Based Stomatology, West China Hospital of Stomatology, Sichuan University, Chengdu, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Mar 13; Vol. 22 (1), pp. 116. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
Child ; Humans ; Adolescent ; Quality of Life ; COVID-19 Vaccines ; Post-Acute COVID-19 Syndrome ; Systematic Reviews as Topic
Czasopismo naukowe
Tytuł:
Perinatal outcomes and sinopharm BBIBP-CorV vaccination during pregnancy.
Autorzy:
Hatami D; Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Habibelahi A; Neonatal Health Office, Ministry of Health and Medical Education, Tehran, Iran.
Changizi N; Maternal Fetal and Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Heidarzadeh M; Department of Neonatology, Zahedan University of Medical Sciences, Zahedan, Iran.
Nojomi M; Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Rast M; Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Ansari K; Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Tehrani-Banihashemi A; Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. .
Pokaż więcej
Źródło:
BMC pregnancy and childbirth [BMC Pregnancy Childbirth] 2024 Mar 11; Vol. 24 (1), pp. 190. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:
Journal Article
MeSH Terms:
Premature Birth*/epidemiology
COVID-19*/epidemiology
COVID-19*/prevention & control
Pregnancy Complications, Infectious*/epidemiology
Pregnancy Complications, Infectious*/prevention & control
Vaccines, Inactivated*
Infant, Newborn ; Pregnancy ; Female ; Humans ; Stillbirth/epidemiology ; Iran/epidemiology ; Retrospective Studies ; Vaccination ; COVID-19 Vaccines/adverse effects ; Pregnancy Outcome
Czasopismo naukowe
Tytuł:
Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period.
Autorzy:
King JP; Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, 1000 North Oak Avenue ML2, Marshfield, WI, 54449, USA. .
Chung JR; Influenza Division, US Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop H24-7, Atlanta, GA, 30329, USA. .
Donahue JG; Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, 1000 North Oak Avenue ML2, Marshfield, WI, 54449, USA.
Martin ET; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
Leis AM; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
Monto AS; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
Gaglani M; Baylor Scott & White Health, Temple, TX, USA.; Texas A&M University College of Medicine, Temple, TX, USA.
Dunnigan K; Baylor Scott & White Research Institute, Temple, TX, USA.
Raiyani C; Baylor Scott & White Research Institute, Temple, TX, USA.
Saydah S; Coronavirus and Other Respiratory Viruses Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Flannery B; Influenza Division, US Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop H24-7, Atlanta, GA, 30329, USA.
Belongia EA; Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, 1000 North Oak Avenue ML2, Marshfield, WI, 54449, USA.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 08; Vol. 24 (1), pp. 300. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
SARS-CoV-2*
COVID-19*/diagnosis
Adult ; Humans ; Outpatients ; COVID-19 Testing ; COVID-19 Vaccines ; Dyspnea ; Fatigue
Czasopismo naukowe
Tytuł:
Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge.
Autorzy:
Chesdachai S; Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. .
Rivera CG; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
Cole KC; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Teaford HR; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
Gonzalez Suarez ML; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Larsen JJ; Department of Nursing, Mayo Clinic, Rochester, MN, USA.
Ganesh R; Department of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Tulledge-Scheitel S; Department of Community Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Razonable RR; Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 05; Vol. 14 (1), pp. 5430. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Journal Article
MeSH Terms:
Outpatients*
COVID-19*
Antibodies, Neutralizing*
Antibodies, Monoclonal, Humanized*
Adenosine Monophosphate/*analogs & derivatives
Alanine/*analogs & derivatives
Humans ; COVID-19 Vaccines ; SARS-CoV-2 ; COVID-19 Drug Treatment
Czasopismo naukowe
Tytuł:
Knowledge, risk perception and uptake of COVID-19 vaccination among internally displaced persons in complex humanitarian emergency setting, Northeast Nigeria.
Autorzy:
Gidado S; Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland. .
Musa M; African Field Epidemiology Network, Borno State Field Office, Maiduguri, Nigeria.
Ba'aba AI; African Field Epidemiology Network, Yobe State Field Office, Damaturu, Nigeria.
Francis MR; Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.
Okeke LA; African Field Epidemiology Network, Adamawa State Field Office, Yola, Nigeria.
Bukar FL; Department of Community Medicine, University of Maiduguri, Maiduguri, Borno State, Nigeria.
Nguku PM; African Field Epidemiology Network, Nigeria Country Office, Abuja, Nigeria.
Hadejia IS; Department of Community Medicine, Ahmadu Bello University, Zaria, Kaduna State, Nigeria.
Hassan IA; Borno State Ministry of Health, Maiduguri, Borno State, Nigeria.
Bande IM; Department of Disease Control and Immunization, Yobe State Primary Health Care Board, Damaturu, Yobe State, Nigeria.
Onuoha M; Nigerian Correctional Service, Adamawa State Office, Yola, Adamawa State, Nigeria.
Usman R; Resolve to Save Lives, Abuja, Nigeria.
Ugbenyo G; African Field Epidemiology Network, Nigeria Country Office, Abuja, Nigeria.
Godwin N; Epidemiology Division, Federal Ministry of Health, Abuja, Nigeria.
Ilori E; Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
Abulfathi AA; Department of Community Medicine, University of Maiduguri, Maiduguri, Borno State, Nigeria.
Mshelia LA; Borno State Primary Health Care Development Agency, Maiduguri, Borno State, Nigeria.
Mohammed AM; World Health Organization, Borno State Office, Maiduguri, Nigeria.
Abdullahi MM; Nigeria Field Epidemiology and Laboratory Training Program, Abuja, Nigeria.
Bammami MI; Yobe State Hospitals Management Board, Damaturu, Yobe State, Nigeria.
Nuorti P; Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.
Atkins S; Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Feb 28; Vol. 24 (1), pp. 634. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Refugees*
Relief Work*
Female ; Humans ; Adolescent ; Young Adult ; Adult ; Male ; COVID-19 Vaccines ; Cross-Sectional Studies ; Nigeria/epidemiology ; Vaccination ; Perception
Czasopismo naukowe
Tytuł:
COVID-19 and COVID-19 vaccination experiences and perceptions and their predictors among community members during the COVID-19 pandemic in Ebonyi state, Nigeria: an analytical cross-sectional study.
Autorzy:
Omale UI; Department of Community Medicine, Alex Ekwueme Federal University Teaching Hospital Abakaliki (AEFUTHA), Abakaliki, Ebonyi State, Nigeria. .
Uduma VU; Department of Internal Medicine, Alex Ekwueme Federal University Teaching Hospital Abakaliki (AEFUTHA), Abakaliki, Ebonyi State, Nigeria.
Adeke AS; Department of Community Medicine, Alex Ekwueme Federal University Teaching Hospital Abakaliki (AEFUTHA), Abakaliki, Ebonyi State, Nigeria.
Ikegwuonu CO; Department of Community Medicine, Alex Ekwueme Federal University Teaching Hospital Abakaliki (AEFUTHA), Abakaliki, Ebonyi State, Nigeria.
Nkwo GE; Department of Community Medicine, Federal Medical Centre Umuahia, Umuahia, Abia State, Nigeria.
Nwali UI; Department of Community Medicine, Alex Ekwueme Federal University Teaching Hospital Abakaliki (AEFUTHA), Abakaliki, Ebonyi State, Nigeria.
Nnachi OO; Department of Community Medicine, Alex Ekwueme Federal University Teaching Hospital Abakaliki (AEFUTHA), Abakaliki, Ebonyi State, Nigeria.
Ukpabi OO; Department of Community Medicine, Alex Ekwueme Federal University Teaching Hospital Abakaliki (AEFUTHA), Abakaliki, Ebonyi State, Nigeria.
Okeke IM; Department of Community Medicine, Alex Ekwueme Federal University Teaching Hospital Abakaliki (AEFUTHA), Abakaliki, Ebonyi State, Nigeria.
Ewah RL; Department of Anaesthesia, Alex Ekwueme Federal University Teaching Hospital Abakaliki (AEFUTHA), Abakaliki, Ebonyi State, Nigeria.; Anaesthesia Unit, Department of Surgery, Ebonyi State University, Abakaliki, Ebonyi State, Nigeria.
Iyare O; Department of Community Medicine, Alex Ekwueme Federal University Teaching Hospital Abakaliki (AEFUTHA), Abakaliki, Ebonyi State, Nigeria.
Oka OU; Department of Community Medicine, Alex Ekwueme Federal University Teaching Hospital Abakaliki (AEFUTHA), Abakaliki, Ebonyi State, Nigeria.
Amuzie CI; Department of Community Medicine, Federal Medical Centre Umuahia, Umuahia, Abia State, Nigeria.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Feb 22; Vol. 24 (1), pp. 567. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Humans ; Nigeria/epidemiology ; COVID-19 Vaccines ; Cross-Sectional Studies ; Pandemics/prevention & control ; Vaccination ; Health Knowledge, Attitudes, Practice
Czasopismo naukowe
Tytuł:
COVID-19 diagnostic testing and vaccinations among First Nations in Manitoba: A nations-based retrospective cohort study using linked administrative data, 2020-2021.
Autorzy:
Nickel NC; Manitoba Centre for Health Policy, Dept of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Phillips-Beck W; First Nations Health and Social Secretariat of Manitoba, Winnipeg, Canada.
Enns JE; Manitoba Centre for Health Policy, Dept of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Ekuma O; Manitoba Centre for Health Policy, Dept of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Taylor C; Manitoba Centre for Health Policy, Dept of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Fileatreault S; Manitoba Centre for Health Policy, Dept of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Eze N; Manitoba Centre for Health Policy, Dept of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Star L; First Nations Health and Social Secretariat of Manitoba, Winnipeg, Canada.
Lavoie J; Dept of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Katz A; Manitoba Centre for Health Policy, Dept of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.; Dept of Family Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Brownell M; Manitoba Centre for Health Policy, Dept of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Mahar A; School of Nursing, Faculty of Health Sciences, Queen's University, Kingston, Canada.
Urquia M; Manitoba Centre for Health Policy, Dept of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Chateau D; National Centre for Epidemiology and Population Health, College of Health and Medicine, Australia National University, Canberra, Australia.
Lix L; Manitoba Centre for Health Policy, Dept of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.; George and Fay Yee Centre for Healthcare Innovation, University of Manitoba, Winnipeg, Canada.
Chartier M; Manitoba Centre for Health Policy, Dept of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Brownell E; Manitoba Centre for Health Policy, Dept of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Tso Deh M; Manitoba Centre for Health Policy, Dept of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Durksen A; Manitoba Centre for Health Policy, Dept of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Romanescu R; Dept of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.; George and Fay Yee Centre for Healthcare Innovation, University of Manitoba, Winnipeg, Canada.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2024 Feb 16; Vol. 21 (2), pp. e1004348. Date of Electronic Publication: 2024 Feb 16 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/diagnosis
COVID-19*/epidemiology
COVID-19*/prevention & control
Indigenous Canadians*
Adolescent ; Adult ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Young Adult ; COVID-19 Testing ; COVID-19 Vaccines ; Manitoba/epidemiology ; Retrospective Studies ; Vaccination
Czasopismo naukowe
Tytuł:
Substantial health and economic burden of COVID-19 during the year after acute illness among US adults at high risk of severe COVID-19.
Autorzy:
Scott A; Global Real World Evidence, Pfizer Inc, New York, NY, USA. .
Ansari W; Global HEOR, Pfizer Inc, New York, NY, USA.
Khan F; Vaccines Medical Development & Scientific Clinical Affairs, Pfizer Inc, New York, NY, USA.
Chambers R; Global Product Development Statistics, Pfizer Inc, New York, NY, USA.
Benigno M; Global Real World Evidence, Pfizer Inc, New York, NY, USA.
Di Fusco M; Global HEOR, Pfizer Inc, New York, NY, USA.
McGrath L; Global Real World Evidence, Pfizer Inc, New York, NY, USA.
Malhotra D; Global Real World Evidence, Pfizer Inc, New York, NY, USA.
Draica F; Medical Affairs, Pfizer Inc, New York, NY, USA.
Nguyen J; Vaccines Medical Development & Scientific Clinical Affairs, Pfizer Inc, New York, NY, USA.
Atkinson J; Medical Affairs, Pfizer Ltd, Tadworth, Surrey, UK.
Atwell JE; Vaccines Medical Development & Scientific Clinical Affairs, Pfizer Inc, New York, NY, USA.
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Feb 01; Vol. 22 (1), pp. 46. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/epidemiology
Adult ; Humans ; United States/epidemiology ; Post-Acute COVID-19 Syndrome ; Financial Stress ; Acute Disease ; COVID-19 Testing ; SARS-CoV-2 ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Willingness to receive COVID-19 vaccines, associated factors and reasons for not taking a vaccine: a cross sectional study among persons aged 13-80 years in Wakiso, Central Uganda.
Autorzy:
Daama A; Africa Medical and Behavioral Sciences Organization, Nansana, Uganda. .; Makerere University School of Public Health, Kampala, Uganda. .
Rashid N; Makerere University School of Public Health, Kampala, Uganda.; Islamic University, Mbale, Uganda.; Mayuge Institute of Global Health Sciences Research and Innovation, Kampala, Uganda.
Asani K; Makerere University School of Public Health, Kampala, Uganda.
Nalwoga GK; Africa Medical and Behavioral Sciences Organization, Nansana, Uganda.
Nalugoda F; Africa Medical and Behavioral Sciences Organization, Nansana, Uganda.
Bulamba R; Africa Medical and Behavioral Sciences Organization, Nansana, Uganda.; Makerere University School of Public Health, Kampala, Uganda.
Kyasanku E; Africa Medical and Behavioral Sciences Organization, Nansana, Uganda.
Nakigozi G; Africa Medical and Behavioral Sciences Organization, Nansana, Uganda.
Kigozi G; Africa Medical and Behavioral Sciences Organization, Nansana, Uganda.
Kagaayi J; Makerere University School of Public Health, Kampala, Uganda.
Mugamba S; Africa Medical and Behavioral Sciences Organization, Nansana, Uganda.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Apr 11; Vol. 24 (1), pp. 391. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Vaccines*
Female ; Humans ; Male ; COVID-19 Vaccines ; Cross-Sectional Studies ; Uganda/epidemiology ; Pandemics ; Vaccination
Czasopismo naukowe
Tytuł:
Implementation of COVID-19 vaccination services in prison in six European countries: translating emergency intervention into routine life-course vaccination.
Autorzy:
Mazzilli S; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Scuola Normale Superiore, Pisa, Italy.
Cocco N; Infectious Diseases Service, Penitentiary Health System, Azienda Socio-Sanitaria Territoriale Santi Paolo e Carlo, Milan, Italy.
Petri D; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Moazen B; Department of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt/Main, Germany.; Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Federal Republic of Germany.
Rosello A; UK Health Security Agency, London, UK.
D'Arcy J; UK Health Security Agency, London, UK.
Plugge E; Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
Baglietto L; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Murauer E; Health Unit of the Villeneuve-les-Maguelone prison, University Hospital Centre Montpellier, Montpellier, France.
Stöver H; Department of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt/Main, Germany.
Trattonikolas T; Ministry of Justice and Public Order - Cyprus Prison Department, Nicosia, Cyprus.
Stylianou I; Ministry of Justice and Public Order - Cyprus Prison Department, Nicosia, Cyprus.
Doltu S; Act For Involvement, Chișinău, Republic of Moldova.
Busmachiu V; National Administration of Penitentiaries, Chișinău, Republic of Moldova.
Mavrou J; Cyprus National Addictions Authority, Nicosia, Cyprus.
Yiasemi I; Cyprus National Addictions Authority, Nicosia, Cyprus.
Barbiros I; National Administration of Penitentiaries, Chișinău, Republic of Moldova.
da Costa FA; Health in Prisons Programme, WHO Regional Office for Europe, Copenhagen, Denmark.
Meroueh F; Health Unit of the Villeneuve-les-Maguelone prison, University Hospital Centre Montpellier, Montpellier, France.
Ranieri R; Infectious Diseases Service, Penitentiary Health System, Azienda Socio-Sanitaria Territoriale Santi Paolo e Carlo, Milan, Italy.
Tavoschi L; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. .
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Apr 10; Vol. 24 (1), pp. 1001. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Prisoners*
Humans ; Prisons ; COVID-19 Vaccines/therapeutic use ; Cross-Sectional Studies ; Life Change Events ; SARS-CoV-2 ; Vaccination
Czasopismo naukowe
Tytuł:
Utilizing direct and indirect information to improve the COVID-19 vaccination booster scheduling.
Autorzy:
Dery Y; Laboratory for Epidemic Modeling and Analysis, Department of Industrial Engineering, Faculty of Engineering, Tel Aviv University, 6997801, Tel Aviv, Israel.; Laboratory for AI, Machine Learning and Business Data Analytics, Tel Aviv University, 6997801, Tel Aviv, Israel.
Yechezkel M; Laboratory for Epidemic Modeling and Analysis, Department of Industrial Engineering, Faculty of Engineering, Tel Aviv University, 6997801, Tel Aviv, Israel.
Ben-Gal I; Laboratory for Epidemic Modeling and Analysis, Department of Industrial Engineering, Faculty of Engineering, Tel Aviv University, 6997801, Tel Aviv, Israel.; Laboratory for AI, Machine Learning and Business Data Analytics, Tel Aviv University, 6997801, Tel Aviv, Israel.
Yamin D; Laboratory for Epidemic Modeling and Analysis, Department of Industrial Engineering, Faculty of Engineering, Tel Aviv University, 6997801, Tel Aviv, Israel. .; Centre for Combatting Pandemics, Tel Aviv University, 6997801, Tel Aviv, Israel. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 06; Vol. 14 (1), pp. 8089. Date of Electronic Publication: 2024 Apr 06.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Influenza Vaccines*
Humans ; COVID-19 Vaccines ; Vaccination ; Hospitalization
Czasopismo naukowe
Tytuł:
Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series.
Autorzy:
Cahuapaza-Gutierrez NL; Facultad de Ciencias de la Salud, Carrera de Medicina Humana, Universidad Científica del Sur, Lima, Perú.; Change Research Working Group, Universidad Científica del Sur, Lima, Perú.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (4), pp. 375-386. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:
Systematic Review; Case Reports; Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Lupus Erythematosus, Systemic*
Female ; Male ; Humans ; Young Adult ; Adult ; Middle Aged ; COVID-19 Vaccines/adverse effects ; SARS-CoV-2 ; Vaccination/adverse effects
Czasopismo naukowe
Tytuł:
Factors affecting different COVID-19 outcomes in patients with systemic lupus erythematosus during the second pandemic wave of COVID-19 in China.
Autorzy:
Liu PC; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Zhang M; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Li JB; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Peng YL; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Yu SJ; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Wu R; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (4), pp. 357-364. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Systemic*/epidemiology
Lupus Erythematosus, Systemic*/complications
COVID-19*/epidemiology
COVID-19*/complications
Humans ; Retrospective Studies ; Pandemics ; COVID-19 Vaccines
Czasopismo naukowe
Tytuł:
Toward trustworthy COVID-19 interventions: Building vaccine trust through community-university partnerships.
Autorzy:
Bray LA; Center for Applied Social Research, University of Oklahoma, Norman, Oklahoma, United States of America.
Jervis LL; Center for Applied Social Research, University of Oklahoma, Norman, Oklahoma, United States of America.; Department of Anthropology, University of Oklahoma, Norman, Oklahoma, United States of America.
Janitz AE; Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.
Ross L; Public Health Institute of Oklahoma, Oklahoma City, Oklahoma, United States of America.
Tallbull G; Center for Applied Social Research, University of Oklahoma, Norman, Oklahoma, United States of America.
VanWagoner TM; Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.; Oklahoma Clinical and Translational Science Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.
Pokaż więcej
Corporate Authors:
CATCH-UP Vaccines Team
Źródło:
PloS one [PLoS One] 2024 Mar 27; Vol. 19 (3), pp. e0300872. Date of Electronic Publication: 2024 Mar 27 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
Humans ; COVID-19 Testing ; Universities ; COVID-19 Vaccines ; Trust ; Vaccination
Czasopismo naukowe
Tytuł:
Lack of association between COVID-19 vaccines and miscarriage onset using a case-crossover design.
Autorzy:
Gastesi Orbegozo I; Biomedical Research Foundation Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain.
Cea-Soriano L; Department of Public Health and Maternal Child Health, Faculty of Medicine, Complutense University of Madrid, Pza. Ramón y Cajal, s/n. Ciudad Universitaria, 28040, Madrid, Spain. .
Llorente A; BIFAP, Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain.
Huerta-Álvarez C; Department of Public Health and Maternal Child Health, Faculty of Medicine, Complutense University of Madrid, Pza. Ramón y Cajal, s/n. Ciudad Universitaria, 28040, Madrid, Spain.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 27; Vol. 14 (1), pp. 7275. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:
Journal Article
MeSH Terms:
Abortion, Spontaneous*/epidemiology
Abortion, Spontaneous*/etiology
COVID-19*/epidemiology
COVID-19*/prevention & control
Female ; Humans ; Pregnancy ; COVID-19 Vaccines/adverse effects ; Cross-Over Studies ; SARS-CoV-2 ; Adult
Czasopismo naukowe
Tytuł:
Epidemiology, clinical features and outcomes of hospitalized patients with COVID-19 by vaccination status: a multicenter historical cohort study.
Autorzy:
Alshanqeeti S; Department of Internal Medicine, Ascension St. John Hospital, 19251 Mack Avenue, Suite 340, 48236, Detroit, MI, USA.
Szpunar S; Department of Biomedical Investigations and Research, Ascension St. John Hospital, Detroit, MI, USA.
Anne P; Department of Internal Medicine, Ascension St. John Hospital, 19251 Mack Avenue, Suite 340, 48236, Detroit, MI, USA.; Department of Pediatrics, Ascension St. John Hospital, Detroit, MI, USA.
Saravolatz L; Department of Internal Medicine, Ascension St. John Hospital, 19251 Mack Avenue, Suite 340, 48236, Detroit, MI, USA.; Division of Infectious Disease, Department of Internal Medicine, Ascension St. John Hospital, Detroit, MI, USA.; Thomas Mackey Center for Infectious Disease Research, Ascension St John Hospital, Detroit, MI, USA.
Bhargava A; Department of Internal Medicine, Ascension St. John Hospital, 19251 Mack Avenue, Suite 340, 48236, Detroit, MI, USA. .; Division of Infectious Disease, Department of Internal Medicine, Ascension St. John Hospital, Detroit, MI, USA. .; Thomas Mackey Center for Infectious Disease Research, Ascension St John Hospital, Detroit, MI, USA. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2024 Mar 21; Vol. 21 (1), pp. 71. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Adult ; Humans ; Female ; Middle Aged ; Aged ; Male ; SARS-CoV-2 ; COVID-19 Vaccines ; Cohort Studies ; Serum Albumin ; Vaccination ; Steroids
Czasopismo naukowe
Tytuł:
Factors associated with vaccine hesitancy against COVID-19 among adults in Europe: a descriptive study analysis applying socio-ecological framework.
Autorzy:
Nagase M; Friede-Springer-Endowed Professorship for Global Child Health, Witten/Herdecke University, Alfred-Herrhausen-Strasse 50, Witten, Germany. .
Pokaż więcej
Źródło:
BMC research notes [BMC Res Notes] 2024 Mar 19; Vol. 17 (1), pp. 84. Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Adult ; Child ; Humans ; Young Adult ; Adolescent ; Vaccination Hesitancy ; COVID-19 Vaccines ; Cross-Sectional Studies ; Europe/epidemiology ; Vaccination
Czasopismo naukowe
Tytuł:
A qualitative examination of primary care team's participation in the distribution of the COVID-19 vaccination.
Autorzy:
Ashcroft R; Factor-Inwentash Faculty of Social Work, University of Toronto, 246 Bloor Street West, Toronto, ON, M5S 1V4, Canada. .
Donnelly C; Faculty of Health Sciences, Queen's University, Kingston, ON, Canada.
Lam S; Factor-Inwentash Faculty of Social Work, University of Toronto, 246 Bloor Street West, Toronto, ON, M5S 1V4, Canada.
Sheffield P; Factor-Inwentash Faculty of Social Work, University of Toronto, 246 Bloor Street West, Toronto, ON, M5S 1V4, Canada.
Hamilton B; Association of Family Health Teams of Ontario, Toronto, ON, Canada.
Kemp C; Frontenac, Lennox, and Addington Ontario Health Team, Kingston, Canada.
Adamson K; Factor-Inwentash Faculty of Social Work, University of Toronto, 246 Bloor Street West, Toronto, ON, M5S 1V4, Canada.
Brown JB; Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Pokaż więcej
Źródło:
BMC primary care [BMC Prim Care] 2024 Mar 14; Vol. 25 (1), pp. 85. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Primary Health Care*
COVID-19*/epidemiology
COVID-19*/prevention & control
Humans ; COVID-19 Vaccines/therapeutic use ; Pandemics ; Vaccination ; Ontario/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies